Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Effectiveness of mRNA COVID-19 vaccines against SARS-CoV-2 infection in a cohort of healthcare personnel.

Literature DB >> 33900384

Effectiveness of mRNA COVID-19 vaccines against SARS-CoV-2 infection in a cohort of healthcare personnel.

Melanie D Swift¹, Laura E Breeher¹, Aaron J Tande², Christopher P Tommaso³, Caitlin M Hainy¹, Haitao Chu⁴, M Hassan Murad¹, Elie F Berbari², Abinash Virk².

Abstract

In a large cohort of US healthcare personnel (HCP) without prior COVID-19 infection, 94,382 doses of mRNA COVID-19 vaccine were administered to 49,220 individuals. The adjusted vaccine effectiveness following two doses of each of the two available brands of mRNA vaccine exceeded 96%.

Entities: Disease

Keywords: COVID-19; SARS-CoV-2; healthcare personnel; mRNA; vaccine effectiveness

Year: 2021 PMID： 33900384 DOI： 10.1093/cid/ciab361

Source DB: PubMed Journal: Clin Infect Dis ISSN： 1058-4838 Impact factor: 9.079

37 in total

Review 1. [Towards COVID-19 control through vaccination: obstacles, challenges and opportunities. SESPAS Report 2022].

Authors: Pere Godoy; Jesús Castilla; Jenaro Astray; Sofía Godoy; José Tuells; Irene Barrabeig; Ángela Domínguez
Journal: Gac Sanit Date: 2022 Impact factor: 2.479

2. [COVID-19 vaccination strategy for employees of German hospitals: results of a survey of infection control practitioners within the B-FAST project].

Authors: Simone Scheithauer; Anna Bludau; Stephanie Heinemann; Martina Anton; Percy Knolle
Journal: Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz Date: 2022-10-21 Impact factor: 1.595

Review 3. Effectiveness of the WHO-Authorized COVID-19 Vaccines: A Rapid Review of Global Reports till 30 June 2021.

Authors: Chang-Jie Cheng; Chun-Yi Lu; Ya-Hui Chang; Yu Sun; Hai-Jui Chu; Chun-Yu Lee; Chang-Hsiu Liu; Cheng-Huai Lin; Chien-Jung Lu; Chung-Yi Li
Journal: Vaccines (Basel) Date: 2021-12-16

4. Effectiveness of COVID-19 vaccines in preventing SARS-CoV-2 infection and hospitalisation, Navarre, Spain, January to April 2021.

Authors: Iván Martínez-Baz; Ana Miqueleiz; Itziar Casado; Ana Navascués; Camino Trobajo-Sanmartín; Cristina Burgui; Marcela Guevara; Carmen Ezpeleta; Jesús Castilla
Journal: Euro Surveill Date: 2021-05

5. SARS-CoV-2 Infections in mRNA Vaccinated Individuals are Biased for Viruses Encoding Spike E484K and Associated with Reduced Infectious Virus Loads that Correlate with Respiratory Antiviral IgG levels.

Authors: Heba H Mostafa; Chun Huai Luo; C Paul Morris; Maggie Li; Nicholas J Swanson; Adannaya Amadi; Nicholas Gallagher; Andrew Pekosz
Journal: medRxiv Date: 2021-07-07

6. Efficacy and effectiveness of COVID-19 vaccines against SARS-CoV-2 infection: interim results of a living systematic review, 1 January to 14 May 2021.

Authors: Thomas Harder; Judith Koch; Sabine Vygen-Bonnet; Wiebe Külper-Schiek; Antonia Pilic; Sarah Reda; Stefan Scholz; Ole Wichmann
Journal: Euro Surveill Date: 2021-07

Review 7. Effectiveness of BNT162b2 and mRNA-1273 Vaccines against COVID-19 Infection: A Meta-Analysis of Test-Negative Design Studies.

Authors: Shuailei Chang; Hongbo Liu; Jian Wu; Wenwei Xiao; Sijia Chen; Shaofu Qiu; Guangcai Duan; Hongbin Song; Rongguang Zhang
Journal: Vaccines (Basel) Date: 2022-03-18

Review 8. Accelerated COVID-19 vaccine development: milestones, lessons, and prospects.

Authors: Karin Bok; Sandra Sitar; Barney S Graham; John R Mascola
Journal: Immunity Date: 2021-08-03 Impact factor: 31.745

9. Real-world effectiveness of BNT162b2 mRNA vaccine: a meta-analysis of large observational studies.

Authors: Chia Siang Kow; Syed Shahzad Hasan
Journal: Inflammopharmacology Date: 2021-07-09 Impact factor: 4.473

Review 10. Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape.

Authors: John S Tregoning; Katie E Flight; Sophie L Higham; Ziyin Wang; Benjamin F Pierce
Journal: Nat Rev Immunol Date: 2021-08-09 Impact factor: 53.106